163 related articles for article (PubMed ID: 37564923)
1. Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy.
Fink CA; Weykamp F; Adeberg S; Bozorgmehr F; Christopoulos P; Lang K; König L; Hörner-Rieber J; Thomas M; Steins M; El-Shafie RA; Rieken S; Bernhardt D; Debus J
Clin Transl Radiat Oncol; 2023 Sep; 42():100665. PubMed ID: 37564923
[TBL] [Abstract][Full Text] [Related]
2. Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy.
Bernhardt D; Aufderstrasse S; König L; Adeberg S; Bozorgmehr F; Christopoulos P; Shafie RAE; Hörner-Rieber J; Kappes J; Thomas M; Herth F; Steins M; Debus J; Rieken S
Cancer Manag Res; 2018; 10():6563-6569. PubMed ID: 30555261
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.
Dreyer J; Bremer M; Henkenberens C
Radiat Oncol; 2018 Nov; 13(1):213. PubMed ID: 30390700
[TBL] [Abstract][Full Text] [Related]
4. Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer.
Holmes OE; MacRae R; Cook G; Cross P; Nair V; Marginean H; Pantarotto JR
Clin Transl Radiat Oncol; 2017 Aug; 5():37-41. PubMed ID: 29594215
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans.
Azar I; Yazdanpanah O; Jang H; Austin A; Kim S; Chi J; Alkassis S; Saha BK; Chopra A; Neu K; Mehdi S; Mamdani H
JAMA Netw Open; 2022 Oct; 5(10):e2237699. PubMed ID: 36264573
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer.
Wang Z; Zhong Y; Zhou Y; Mao F; Zhang X; Wang C; Sun Q
Clin Interv Aging; 2023; 18():1163-1174. PubMed ID: 37525754
[TBL] [Abstract][Full Text] [Related]
7. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients.
Di Donato V; Page Z; Bracchi C; Tomao F; Musella A; Perniola G; Panici PB
J Gynecol Oncol; 2019 Jan; 30(1):e6. PubMed ID: 30479090
[TBL] [Abstract][Full Text] [Related]
8. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
[TBL] [Abstract][Full Text] [Related]
11. The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients.
Zhou S; Zhang XH; Zhang Y; Gong G; Yang X; Wan WH
Cancer Manag Res; 2022; 14():1683-1691. PubMed ID: 35573259
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma.
Cai C; Tao L; Li D; Wang L; Xiao E; Luo G; Yan Z; Wang Y; Li D
Scand J Gastroenterol; 2024 Mar; 59(3):333-343. PubMed ID: 38018772
[TBL] [Abstract][Full Text] [Related]
13. Age-adjusted Charlson comorbidity index is associated with the risk of osteoporosis in older fall-prone men: a retrospective cohort study.
Pan ZM; Zeng J; Li T; Hu F; Cai XY; Wang XJ; Liu GZ; Hu XH; Yang X; Lu YH; Liu MY; Gong YP; Liu M; Li N; Li CL
BMC Geriatr; 2024 May; 24(1):413. PubMed ID: 38730354
[TBL] [Abstract][Full Text] [Related]
14. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
[TBL] [Abstract][Full Text] [Related]
15. Impact of Comorbidity Scores on the Overall Survival of Patients With Advanced Non-small Cell Lung Cancer: A Real-World Experience From Eastern India.
M SG; Mohapatra PR; Bhuniya S; Das Majumdar SK; Mishra P; Panigrahi MK; Bal SK; Datta A; Venkatachalam P; Chatterjee D
Cureus; 2022 Oct; 14(10):e30589. PubMed ID: 36420233
[TBL] [Abstract][Full Text] [Related]
16. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
17. Association of high-risk comorbidity with overall survival among patients with gastric cancer and its sex-specific differences in China: a retrospective observational cohort study.
Wu J; Tian S; Xu J; Cheng N; Chen X; Yin J; Nie Z
BMC Cancer; 2023 Sep; 23(1):916. PubMed ID: 37770842
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
19. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
[TBL] [Abstract][Full Text] [Related]
20. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]